UBS AG Offers $750 Million in Contingent Yield Notes
UBS AG announces a $750 million offering of Trigger Autocallable Contingent Yield Notes linked to Microchip Technology's stock, introducing significant investment risks.
Barclays Bank announces $1.1 million in new notes
Barclays Bank PLC files a pricing supplement for $1.1 million in autocallable notes linked to CoreWeave, signaling a strategic move in the banking sector.
UBS AG Offers $107,750 Trigger Autocallable Notes
UBS AG announces the offering of Trigger Autocallable Contingent Yield Notes linked to Alaska Air Group's stock, highlighting risks and potential returns.
H.I.G. ADV II Emperor Co-Investment files new offering
H.I.G. ADV II Emperor Co-Investment, L.P. files a new offering under Rule 506(b) to raise capital in the private equity sector.
UBS AG Files Preliminary Pricing Supplement for New Notes
UBS AG has filed a preliminary pricing supplement for Trigger Autocallable Contingent Yield Notes linked to Corning Incorporated, expanding its offerings.
JPMorgan Chase Financial Co. launches Bear Market PLUS product
JPMorgan Chase Financial Co. LLC introduces Bear Market PLUS, a structured investment product offering inverse exposure to the S&P 500 Index.
Morgan Stanley Finance LLC Files Pricing Supplement for New Securities
Morgan Stanley Finance LLC has filed a pricing supplement for new structured securities, enhancing its product offerings in the financial sector.
Bambusa Therapeutics grants stock options to director Liang Howard
Bambusa Therapeutics has filed a report revealing stock options granted to director Liang Howard, indicating a strategic move to align executive interests with shareholders.
Bambusa Therapeutics Reports Insider Transactions on Preferred Stock
Bambusa Therapeutics reveals insider transactions involving its Series A-1 and A-2 Preferred Stock, signaling investor confidence ahead of IPO.
Bambusa Therapeutics reports major ownership changes
Bambusa Therapeutics, Inc. announces significant ownership changes involving Helmut Wolfgang Jeggle, impacting the biological products industry.
Salvia Investment reveals major stake in Bambusa Therapeutics
Salvia Investment GmbH discloses substantial ownership in Bambusa Therapeutics, signaling a strong commitment to the biotech sector.
Tucker Aaron acquires 1,500 shares of Unity Bancorp
Tucker Aaron reports acquisition of 1,500 shares of Unity Bancorp, increasing total ownership to 89,218 shares, as detailed in SEC filing.
AMCON's CEO Atayan Reports Stock Transaction of 14,850 Shares
AMCON Distributing Co's CEO Christopher H. Atayan reports a stock transaction involving 14,850 restricted shares, reflecting his ongoing commitment to the company.
Schmaderer Charles J. acquires shares in AMCON Distributing
Charles J. Schmaderer reports acquisition of shares in AMCON Distributing, reflecting ongoing changes in the wholesale groceries industry.
Sanchez makes notable stock transactions at Texas Instruments
Robert E. Sanchez reports significant stock transactions involving Texas Instruments, reflecting ongoing insider activity in the semiconductor industry.
Mobileye Global reports strong Q3 results, boosts growth outlook
Mobileye Global Inc. posts impressive Q3 results, showcasing revenue growth and advancements in autonomous technology, signaling strong market positioning.
Cherry Hill Mortgage Investment Corp reports Q3 2026 results
Cherry Hill Mortgage Investment Corp files 10-Q for Q3 2026, showcasing financial performance and strategic insights amid market challenges.
Patsley reports major stock transactions at Texas Instruments
Pamela H. Patsley reported significant stock transactions involving Texas Instruments, reflecting ongoing changes in executive ownership at the semiconductor giant.
Silvercrest Asset Management reports Q3 results, shows growth
Silvercrest Asset Management Group Inc. reports positive Q3 results, indicating growth in investment advisory services amid market fluctuations.
PTC Therapeutics reports Q3 2026 results, shows growth
PTC Therapeutics, Inc. shares its Q3 2026 results, indicating growth and ongoing innovation in the pharmaceutical preparations industry.